Edge Capital Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,958
| Closed | -$230K | – | 304 |
|
|
2023
Q3 | $230K | Sell |
3,958
-19,376
| -83% | -$1.12M | 0.01% | 265 |
|
|
2023
Q2 | $1.49M | Buy |
23,334
+992
| +4% | +$63.4K | 0.09% | 149 |
|
|
2023
Q1 | $1.55M | Buy |
22,342
+18,978
| +564% | +$1.32M | 0.1% | 141 |
|
|
2022
Q4 | $242K | Sell |
3,364
-279
| -8% | -$20.1K | 0.02% | 262 |
|
|
2022
Q3 | $259K | Sell |
3,643
-125
| -3% | -$8.89K | 0.02% | 244 |
|
|
2022
Q2 | $290K | Buy |
3,768
+761
| +25% | +$58.6K | 0.03% | 232 |
|
|
2022
Q1 | $220K | Sell |
3,007
-1,186
| -28% | -$86.8K | 0.02% | 271 |
|
|
2021
Q4 | $261K | Buy |
4,193
+698
| +20% | +$43.4K | 0.02% | 245 |
|
|
2021
Q3 | $207K | Hold |
3,495
| – | – | 0.02% | 265 |
|
|
2021
Q2 | $234K | Sell |
3,495
-860
| -20% | -$57.6K | 0.02% | 242 |
|
|
2021
Q1 | $275K | Buy |
4,355
+100
| +2% | +$6.32K | 0.02% | 234 |
|
|
2020
Q4 | $264K | Sell |
4,255
-1,691
| -28% | -$105K | 0.02% | 222 |
|
|
2020
Q3 | $358K | Buy |
5,946
+60
| +1% | +$3.61K | 0.04% | 181 |
|
|
2020
Q2 | $346K | Buy |
5,886
+1,578
| +37% | +$92.8K | 0.04% | 177 |
|
|
2020
Q1 | $240K | Buy |
4,308
+197
| +5% | +$11K | 0.03% | 186 |
|
|
2019
Q4 | $264K | Buy |
+4,111
| New | +$264K | 0.03% | 205 |
|
|
2019
Q3 | – | Sell |
-5,766
| Closed | -$261K | – | 231 |
|
|
2019
Q2 | $261K | Buy |
5,766
+914
| +19% | +$41.4K | 0.03% | 224 |
|
|
2019
Q1 | $231K | Sell |
4,852
-595
| -11% | -$28.3K | 0.02% | 219 |
|
|
2018
Q4 | $283K | Buy |
+5,447
| New | +$283K | 0.03% | 204 |
|